André N. Vis

6.1k citations

177 papers · 4.0k indexed · 1 hit paper · h-index 34

Pulmonary and Respiratory Medicine top 0.5%
- Prostate Cancer Treatment and Research 113
- Prostate Cancer Diagnosis and Treatment 105
Urology top 1%
Cancer Research top 5%
- Cancer, Lipids, and Metabolism 13
Rheumatology top 2%
- Urologic and reproductive health conditions 32
Surgery top 2%
- Bladder and Urothelial Cancer Treatments 32
- Urinary and Genital Oncology Studies 23
Radiology, Nuclear Medicine and Imaging
- Radiopharmaceutical Chemistry and Applications 23
Endocrinology, Diabetes and Metabolism
- Hormonal and reproductive studies 14

Co-authors: Theodorus van der Kwast Fritz H. Schröder R. Jeroen A. van Moorselaar Ries Kranse Robert F. Hoedemaeker Bas W.G. van Rhijn Ellen C. Zwarthoff Daniela E. Oprea‐Lager
Cited by: Pulmonary and Respiratory Medicine Urology Cancer Research
Journals: British Journal of Urology (19 papers)European Urology (15 papers)The Journal of Urology (12 papers)
Partner nations: Netherlands United Kingdom United States

In The Last Decade

André N. Vis

161 papers receiving 3.9k citations

Hit Papers

align trajectories log scale

Peers

Countries citing papers authored by André N. Vis

Since Specialization

Citations

This map shows the geographic impact of André N. Vis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by André N. Vis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites André N. Vis more than expected).

Fields of papers citing papers by André N. Vis

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by André N. Vis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by André N. Vis. The network helps show where André N. Vis may publish in the future.

Co-authorship network

The 25 scholars most cited alongside André N. Vis, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with André N. Vis Line = papers co-authored together André N. Vis links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	A Comparison of Globally Applied Prognostic Risk Groups and the Prevalence of Metastatic Disease on Prostate-specific Membrane Antigen Positron Emission Tomography in Patients with Newly Diagnosed Prostate Cancer European Urology Oncology ·Zoran Iličković,Liselotte M.S. Boevé,Evelyn Wellington,Dennie Meijer,Paula Fernanda Cavalli Picoloto,E. Quilin,Remco J.J. Knol,Ton A. Roeleveld,Fred Paterson,Azila Dason,李广瑜,R. Jeroen A. van Moorselaar,Pim J. van Leeuwen,Matthijs C. F. Cysouw,Daniela E. Oprea‐Lager,André N. Vis	2024	7
2	Prostate Cancer–related Events in Patients with Synchronous Metastatic Hormone-sensitive Prostate Cancer Treated with Androgen Deprivation Therapy with and Without Concurrent Radiation Therapy to the Prostate; Data from the HORRAD Trial European Urology ·Liselotte M.S. Boevé,Maarten C.C.M. Hulshof,Paul C.M.S. Verhagen,Jos W. R. Twisk,Wim P.J. Witjes,Peter de Vries,R. Jeroen A. van Moorselaar,André N. Vis,George van Andel	2024	2
3	Treating Primary Node-Positive Prostate Cancer: A Scoping Review of Available Treatment Options Cancers ·V. S. Mandrusova,Hilda A. de Barros,杜敬星,André N. Vis,Andries M. Bergman,Floris J. Pos,Reem Shalash Alshammari,Henk G. van der Poel,Wouter V. Vogel,Pim J. van Leeuwen	2023	2
4	Histopathological Concordance between Prostate Biopsies and Radical Prostatectomy Specimens – Implications of Transrectal and Transperineal Biopsy Approaches European Urology Open Science ·Mjad Khiami,Sub-Saharian Africa,W. A. Al-Rashid,Liu Chun-shu,Kurdo Barwari,Л.А. Анисько,Cássio Cassel,A.M.E. Claessen,Gildásio Macedo Oliveira,Vincent van der Noort,Martijn Smeenge,Ton A. Roeleveld,E. Borotvás,Menren Xuan,Azila Dason,André N. Vis,Elise M. Bekers,Pim J. van Leeuwen,Henk G. van der Poel	2023	1
5	The conundrum of treating metastatic hormone sensitive prostate cancer European Urology Open Science ·Suelane Carvalho Monteiro,Niven Mehra,André N. Vis,刘月荣,Murray Hyne,Joyce M. van Dodewaard-de Jong,Pieter L. van den Berg,Jules Lavalaye,Shafak Aluwini,Haiko J. Bloemendal,Peter F.A. Mulders,Mohapatra Sradhanjali	2023	0
6	TripleAiM1: a nationwide registry of de novo metastatic hormone-sensitive prostate cancer with prospective quality-of-life assessment BMJ Open ·Carla Barela‐Bloom,Jean‐Paul A. van Basten,Pieter L. van den Berg,Roderick CN van den Bergh,临军,Joyce M. van Dodewaard-de Jong,Mathijs P. Hendriks,Sjoerd Klaver,Zarina S. Lalmahomed,Murray Hyne,Addy C.M. van de Luijtgaarden,L.A.J. Roelofs,André N. Vis,Gerard Vreugdenhil,Melissa Guzicki,刘月荣,Haiko J. Bloemendal,Peter F.A. Mulders,Niven Mehra	2023	1
7	Using prostate‐specific membrane antigen positron‐emission tomography to guide prostate biopsies and stage men at high‐risk of prostate cancer British Journal of Urology ·Yves J. L. Bodar,Liselotte M.S. Boevé,Pim J. van Leeuwen,Danielly Fagundes dos Santos,Jakko A. Nieuwenhuijzen,Ernst P. van Haarst,Jorg R. Oddens,Maarten L. Donswijk,Kun Qian,Matthijs J. Scheltema,Dennie Meijer,Yasser A. Aldabbagh,Daniela E. Oprea‐Lager,André N. Vis	2023	7
8	Identifying Patients in Whom the Follow-Up Scheme after Robot-Assisted Radical Prostatectomy Could Be Optimized in the First Year after Surgery: Reducing Healthcare Burden Biomedicines ·Liu Chun-shu,Stanislav A. UTTS,Dennie Meijer,Evelyn Wellington,Corinne Tillier,Pim J. van Leeuwen,Henk G. van der Poel,André N. Vis	2023	0
9	Reproducibility of tumor staging depends on the applied PSMA-radiotracer - A retrospective analysis on the interobserver variability of PSMA-PET/CT European Urology Open Science ·І. В. Варнавська,Daniela E. Oprea‐Lager,André N. Vis,Mariëlle J. Wondergem,Maarten L. Donswijk,Dennie Meijer,Louise Emmett,Pim J. van Leeuwen,H.G. Van Der Poel	2021	1
10	Detection of intraprostatic tumor localisation with 18-Fluorine Prostate-Specific Membrane Antigen (PSMA) PET/CT compared to radical prostatectomy specimens: Is PSMA-targeted biopsy feasible? the DeTeCT trial European Urology Open Science ·Yves J. L. Bodar,B.H.E. Jansen,Jose Emmanuel B. Tecson,Gerben J.C. Zwezerijnen,Jakko A. Nieuwenhuijzen,N. Harry Hendrikse,R. Jeroen A. van Moorselaar,Daniela E. Oprea‐Lager,André N. Vis	2020	1
11	Prospective evaluation of pelvic lymph node staging with 18fluorine prostate-specific membrane antigen PET/CT prior to extended lymph node dissection in primary prostate cancer – the SALT trial European Urology Open Science ·B.H.E. Jansen,Yves J. L. Bodar,Gerben J.C. Zwezerijnen,Jakko A. Nieuwenhuijzen,Maurits Wondergem,Ton A. Roeleveld,O.S. Hoektra,Jeroen van Moorselaar,Daniela E. Oprea‐Lager,André N. Vis	2020	1
12	Detection of Recurrent Prostate Cancer Using Prostate-specific Membrane Antigen Positron Emission Tomography in Patients not Meeting the Phoenix Criteria for Biochemical Recurrence After Curative Radiotherapy European Urology Oncology ·B.H.E. Jansen,Pim J. van Leeuwen,Maurits Wondergem,Tim M. van der Sluis,Jakko A. Nieuwenhuijzen,Remco J.J. Knol,R. Jeroen A. van Moorselaar,Henk G. van der Poel,Daniela E. Oprea‐Lager,André N. Vis	2020	46
13	Prostate Specific Membrane Antigen Positron Emission Tomography/Computerized Tomography in the Evaluation of Initial Response in Candidates Who Underwent Salvage Radiation Therapy after Radical Prostatectomy for Prostate Cancer The Journal of Urology ·Dennie Meijer,A. R. Sharifulin,Pim J. van Leeuwen,Sebastiaan Remmers,B.H.E. Jansen,Yves J. L. Bodar,何淑宜,Eva E. Schaake,Henk G. van der Poel,Maurits Wondergem,Martijn B. Busstra,Jakko A. Nieuwenhuijzen,Philip Meijnen,Tessa Brabander,R. Jeroen A. van Moorselaar,N. Harry Hendrikse,Daniela E. Oprea‐Lager,Monique J. Roobol,André N. Vis	2020	4
14	Clinical verification of 18F-DCFPyL PET-detected lesions in patients with biochemically recurrent prostate cancer PLoS ONE ·Dennie Meijer,B.H.E. Jansen,Maurits Wondergem,Yves J. L. Bodar,Fred Paterson,Annelies Vellekoop,薮崎志穂,Friso M. van der Zant,Otto S. Hoekstra,Jakko A. Nieuwenhuijzen,Max Dahele,André N. Vis,Daniela E. Oprea‐Lager	2020	9
15	Patient-reported Quality of Life in Patients with Primary Metastatic Prostate Cancer Treated with Androgen Deprivation Therapy with and Without Concurrent Radiation Therapy to the Prostate in a Prospective Randomised Clinical Trial; Data from the HORRAD Trial European Urology ·Liselotte M.S. Boevé,Maarten C.C.M. Hulshof,Paul C.M.S. Verhagen,Jos W. R. Twisk,Wim P.J. Witjes,Peter de Vries,R. Jeroen A. van Moorselaar,George van Andel,André N. Vis	2020	23
16	Pelvic lymph-node staging with 18F-DCFPyL PET/CT prior to extended pelvic lymph-node dissection in primary prostate cancer - the SALT trial - European Journal of Nuclear Medicine and Molecular Imaging ·B.H.E. Jansen,Yves J. L. Bodar,Gerben J.C. Zwezerijnen,Dennie Meijer,J. Patrick van der Voorn,Jakko A. Nieuwenhuijzen,Maurits Wondergem,Ton A. Roeleveld,Ronald Boellaard,Otto S. Hoekstra,R. Jeroen A. van Moorselaar,Daniela E. Oprea‐Lager,André N. Vis	2020	78
17	Objectifying grade in Ta-T1 urothelial carcinomas of the bladder using proliferative and quantitative markers: A multicentre study in 310 bladder tumors Urologic Oncology Seminars and Original Investigations ·Judith Bosschieter,Anouk E. Hentschel,C. Dilara Savci‐Heijink,J. Patrick van der Voorn,Ya. V. Dolinov,André N. Vis,S R. Pierce,Birgit I. Lissenberg‐Witte,R. Jeroen A. van Moorselaar,Jakko A. Nieuwenhuijzen	2019	3
18	An immediate, single intravesical instillation of mitomycin C is of benefit in patients with non–muscle-invasive bladder cancer irrespective of prognostic risk groups Urologic Oncology Seminars and Original Investigations ·Judith Bosschieter,Jakko A. Nieuwenhuijzen,André N. Vis,A. Skruch,Birgit I. Lissenberg‐Witte,Goedele M.A. Beckers,R. Jeroen A. van Moorselaar	2018	13
19	Robot-assisted Laparoscopic Implantation of Brachytherapy Catheters in Bladder Cancer European Urology ·Judith Bosschieter,André N. Vis,Henk G. van der Poel,L. Moonen,Simon Horenblas,Bas W.G. van Rhijn,Bradley R. Pieters,Jakko A. Nieuwenhuijzen,Kees Hendricksen	2017	5
20	Value of an Immediate Intravesical Instillation of Mitomycin C in Patients with Non–muscle-invasive Bladder Cancer: A Prospective Multicentre Randomised Study in 2243 patients European Urology ·Judith Bosschieter,Jakko A. Nieuwenhuijzen,A. Skruch,André N. Vis,Birgit I. Lissenberg‐Witte,Don Newling,Goedele M.A. Beckers,R. Jeroen A. van Moorselaar	2017	79

About André N. Vis

André N. Vis is a scholar working on Pulmonary and Respiratory Medicine, Urology and Rheumatology, having authored 177 papers that have together received 4.0k indexed citations. Recurring topics across this work include Prostate Cancer Treatment and Research (113 papers), Prostate Cancer Diagnosis and Treatment (105 papers), Bladder and Urothelial Cancer Treatments (32 papers), Urologic and reproductive health conditions (32 papers), Radiopharmaceutical Chemistry and Applications (23 papers), Urinary and Genital Oncology Studies (23 papers), Hormonal and reproductive studies (14 papers) and Cancer, Lipids, and Metabolism (13 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (2.6k citations), Urology (286 citations) and Cancer Research (551 citations). André N. Vis has collaborated with scholars based in Netherlands, United Kingdom and United States. Frequent co-authors include Theodorus van der Kwast, Fritz H. Schröder, R. Jeroen A. van Moorselaar, Ries Kranse, Robert F. Hoedemaeker, Bas W.G. van Rhijn, Ellen C. Zwarthoff, Daniela E. Oprea‐Lager, Jakko A. Nieuwenhuijzen and Egbert R. Boevé. Their work appears in journals such as British Journal of Urology, European Urology, The Journal of Urology, Journal of Nuclear Medicine and European Journal of Nuclear Medicine and Molecular Imaging.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact